{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:18:46Z","timestamp":1787836726118,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>End-stage renal disease (ESRD) patients undergoing renal replacement therapy (RRT) are at increased risk of infections, inflammatory disorders, and malignancies because of immune dysfunction, repeated vascular access procedures, and immunosuppressive therapy after kidney transplantation. Fever of unknown origin (FUO) is particularly challenging to investigate in this population, and evidence regarding the role of [18\u00a0F]FDG PET\/CT remains limited. This study evaluated the diagnostic performance, clinical impact, and predictors of positive [18\u00a0F]FDG PET\/CT findings in ESRD patients with FUO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included ESRD patients receiving hemodialysis, peritoneal dialysis, or kidney transplantation who underwent [18\u00a0F]FDG PET\/CT for FUO between 2014 and 2021. PET\/CT findings were compared with the final diagnosis established by microbiological, histopathological, imaging, laboratory, and follow-up data. Sensitivity, specificity, predictive values, likelihood ratios, and diagnostic accuracy were calculated. Clinical impact was assessed according to the influence of PET\/CT on diagnostic and therapeutic management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-seven patients were retrospectively included, 53 (61%) on hemodialysis, 27 (31%) on peritoneal dialysis, and 7 (8%) after kidney transplantation. [18\u00a0F]FDG PET\/CT was positive in 57 cases (65%). Final diagnoses included infectious diseases in 36 patients, non-infectious inflammatory diseases in 20, malignancies in 10, while no diagnosis was established in 21. The most common infectious causes were catheter-related bloodstream infection, infective endocarditis, spondylodiscitis, pneumonia, and vascular graft infection; large-vessel vasculitis was the predominant inflammatory disease, and lymphoma the most frequent malignancy. PET\/CT achieved a sensitivity of 77%, specificity of 71%, positive predictive value of 89.5%, negative predictive value of 50%, and overall accuracy of 76%. Elevated C-reactive protein, erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio, and longer hospitalization independently predicted positive PET\/CT findings. PET\/CT influenced clinical management in 66 patients (76%) by guiding targeted therapy, invasive diagnostic procedures, additional investigations, or avoiding unnecessary interventions after negative examinations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>[18\u00a0F]FDG PET\/CT demonstrates good diagnostic accuracy and substantial clinical impact in ESRD patients with FUO receiving RRT. These findings support the early integration of PET\/CT into the diagnostic work-up of this high-risk population, particularly in patients with elevated inflammatory biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12149-026-02277-y","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:35:15Z","timestamp":1787834115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F]FDG PET\/CT role in FUO among patients with end-stage renal disease on renal replacement therapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-6494","authenticated-orcid":false,"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2277_CR1","first-page":"493","volume":"104","author":"N Wouk","year":"2021","unstructured":"Wouk N. End-Stage Renal Disease: medical Management. Am Fam Physician. 2021;104:493\u20139.","journal-title":"Am Fam Physician"},{"key":"2277_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.13119","volume":"192","author":"J Tecklenborg","year":"2018","unstructured":"Tecklenborg J, Clayton D, Siebert S, Coley SM. The role of the immune system in kidney disease. Clin Exp Immunol. 2018;192:142\u201350.","journal-title":"Clin Exp Immunol"},{"key":"2277_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3:1526\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2277_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","volume":"65","author":"AM Butler","year":"2015","unstructured":"Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB, et al. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996\u20132009. Am J Kidney Dis. 2015;65:763\u201372.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2277_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.23736\/S1824-4785.25.03649-0","volume":"69","author":"D Albano","year":"2025","unstructured":"Albano D, Rodella C, Guarneri A, Romano Gargarella E, Leccisotti L. [18F]FDG PET\/CT of FUO\/IUO in special populations. Q J Nucl Med Mol Imaging. 2025;69(3):219\u201323. https:\/\/doi.org\/10.23736\/S1824-4785.25.03649-0.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"9","key":"2277_CR6","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00259-024-06732-8","volume":"51","author":"S Hess","year":"2024","unstructured":"Hess S, Noriega-\u00c1lvarez E, Leccisotti L, Treglia G, Albano D, Roivainen A, Glaudemans AWJM, Gheysens O. EANM consensus document on the use of [18F]FDG PET\/CT in fever and inflammation of unknown origin. Eur J Nucl Med Mol Imaging. 2024;51(9):2597\u2013613. https:\/\/doi.org\/10.1007\/s00259-024-06732-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2277_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1053\/j.semnuclmed.2026.03.010","volume":"56","author":"D Albano","year":"2026","unstructured":"Albano D, Urso L, Treglia G, Bertagna F. The value of [18F]FDG PET\/CT in fever of unknown origin (FUO): an update and future aspects. Semin Nucl Med. 2026;56(4):702\u20138. https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.03.010.","journal-title":"Semin Nucl Med"},{"issue":"6","key":"2277_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2967\/jnumed.125.271525","volume":"67","author":"D Albano","year":"2026","unstructured":"Albano D, Lanfranchi F, Bauckneht M, Massollo M, Piccardo A, Balma M, Peano S, Liberini V, Coccarelli A, Morbelli S, Laudicella R, Giacoppo G, Capitanio S, Franchini A, Muni A, Miceli A, Piva R, Abenavoli E, Linguanti F, Filice A, Durmo R, Ferrari C, Battisti C, Rubini G, Santo G, Busnardo E, Chiti A, Deandreis D, Bertagna F. Diagnostic Yield of [18F]FDG PET\/CT in FUO: An Italian Multicenter Study of 929 Patients. J Nucl Med. 2026;67(6):988\u201394. https:\/\/doi.org\/10.2967\/jnumed.125.271525.","journal-title":"J Nucl Med"},{"key":"2277_CR9","first-page":"70","volume":"22","author":"IO Lawal","year":"2019","unstructured":"Lawal IO, Popoola GO, Lengana T, Ankrah AO, Ebenhan T. SathekgeMM. Diagnostic utility of 18F-FDG PET\/CT in fever of unknown origin among patients with end-stage renal disease treated with renal replacement therapy. Hell J Nucl Med. 2019;22:70\u20135.","journal-title":"Hell J Nucl Med"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/hdi.12471","volume":"21","author":"K Tek Chand","year":"2017","unstructured":"Tek Chand K, Chennu KK, Amancharla Yadagiri L, Manthri Gupta R, Rapur R, Vishnubotla SK. Utility of 18 F-FDG PET\/CT scan to diagnose the etiology of fever of unknown origin in patients on dialysis. Hemodial Int. 2017;21:224\u201331.","journal-title":"Hemodial Int"},{"issue":"5","key":"2277_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2967\/jnumed.114.151696","volume":"56","author":"JR Tseng","year":"2015","unstructured":"Tseng JR, Lin CW, Chen SH, Yen TH, Lin PY, Lee MH, Yen TC. Clinical Usefulness of \u00b9\u2078F-FDG PET\/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis. J Nucl Med. 2015;56(5):681\u20137. https:\/\/doi.org\/10.2967\/jnumed.114.151696.","journal-title":"J Nucl Med"},{"key":"2277_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.amjmed.2024.07.015","volume":"137","author":"WF Wright","year":"2024","unstructured":"Wright WF, Wang J, Auwaerter PG. Fever of unknown origin (FUO) criteria influences diagnostic outcomes: a systematic review and meta-analysis. Am J Med. 2024;137:1246\u201354. .e6.","journal-title":"Am J Med"},{"key":"2277_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2967\/jnumed.112.112524","volume":"54","author":"F Jamar","year":"2013","unstructured":"Jamar F, Buscombe J, Chiti A, et al. EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647\u201358.","journal-title":"J Nucl Med"},{"issue":"10","key":"2277_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3109\/08860220903216048","volume":"31","author":"R Okada","year":"2009","unstructured":"Okada R, Yuzawa Y, Kawamura T, Hamajima N, Watanabe Y, Matsuo S. Incidence of fever of unknown origin and subsequent antitubercular medications in hemodialysis patients: a two-year prospective study. Ren Fail. 2009;31(10):863\u20138.","journal-title":"Ren Fail"},{"issue":"1","key":"2277_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.23736\/S1824-4785.25.03618-0","volume":"69","author":"AA Nawwar","year":"2025","unstructured":"Nawwar AA, Hess S, Leccisotti L, Jamar F, Noriega-Alvarez E, Albano D, Gheysens O. Role of FDG PET\/CT in bacteremia and fever of unknown origin: a pictorial overview of finding the culprit. Q J Nucl Med Mol Imaging. 2025;69(1):4\u201316. https:\/\/doi.org\/10.23736\/S1824-4785.25.03618-0.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"6","key":"2277_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/0284185118799512","volume":"60","author":"Y Kan","year":"2019","unstructured":"Kan Y, Wang W, Liu J, Yang J, Wang Z. Contribution of 18F-FDG PET\/CT in a case-mix of fever of unknown origin and inflammation of unknown origin: a meta-analysis. Acta Radiol. 2019;60(6):716\u201325. https:\/\/doi.org\/10.1177\/0284185118799512.","journal-title":"Acta Radiol"},{"issue":"12","key":"2277_CR17","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2967\/jnumed.116.174391","volume":"57","author":"M Takeuchi","year":"2016","unstructured":"Takeuchi M, Dahabreh IJ, Nihashi T, Iwata M, Varghese GM, Terasawa T. Nuclear Imaging for Classic Fever of Unknown Origin: Meta-Analysis. J Nucl Med. 2016;57(12):1913\u20139. https:\/\/doi.org\/10.2967\/jnumed.116.174391.","journal-title":"J Nucl Med"},{"issue":"4","key":"2277_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40336-021-00445-w","volume":"9","author":"M Casali","year":"2021","unstructured":"Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D\u2019Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of 18F-FDG PET\/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging. 2021;9(4):299\u2013339. https:\/\/doi.org\/10.1007\/s40336-021-00445-w.","journal-title":"Clin Transl Imaging"},{"issue":"1182","key":"2277_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/bjr\/tqag068","volume":"99","author":"D Albano","year":"2026","unstructured":"Albano D, Lauri C, Signore A, Treglia G. Nuclear medicine imaging to guide antibiotic therapy: an expert review. Br J Radiol. 2026;99(1182):1024\u201335. https:\/\/doi.org\/10.1093\/bjr\/tqag068.","journal-title":"Br J Radiol"},{"issue":"1","key":"2277_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41824-025-00263-7","volume":"9","author":"D Albano","year":"2025","unstructured":"Albano D, Rizzo A, Guarneri A, Leccisotti L, Rodella C, Treglia G. Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review. EJNMMI Rep. 2025;9(1):28. https:\/\/doi.org\/10.1186\/s41824-025-00263-7.","journal-title":"EJNMMI Rep"},{"issue":"6","key":"2277_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","volume":"51","author":"JP Pijl","year":"2021","unstructured":"Pijl JP, Nienhuis PH, Kwee TC, Glaudemans AWJM, Slart RHJA, Gormsen LC. Limitations and Pitfalls of FDG-PET\/CT in Infection and Inflammation. Semin Nucl Med. 2021;51(6):633\u201345. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.06.008.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"2277_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12149-017-1226-8","volume":"32","author":"AM Garc\u00eda-Vicente","year":"2018","unstructured":"Garc\u00eda-Vicente AM, Tello-Gal\u00e1n MJ, Amo-Salas M, Ros-Izquierdo J, Jim\u00e9nez-Londo\u00f1o GA, La Rosa Salas B, Prado-Serrano Pradas G, Pena-Pardo FJ, Soriano-Castrej\u00f3n \u00c1. Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET\/CT in patients with fever of unknown origin? Ann Nucl Med. 2018;32(2):123\u201331. https:\/\/doi.org\/10.1007\/s12149-017-1226-8.","journal-title":"Ann Nucl Med"},{"issue":"7","key":"2277_CR23","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s11547-025-02005-y","volume":"130","author":"D Albano","year":"2025","unstructured":"Albano D, Rodella C, Calabr\u00f2 A, Glaudemans AWJM, Treglia G, Bertagna F. The diagnostic role of 2-[18F]FDG PET\/CT in critically ill patients with suspected infection of unknown origin: a real-world experience. Radiol Med. 2025;130(7):1074\u201383. https:\/\/doi.org\/10.1007\/s11547-025-02005-y.","journal-title":"Radiol Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02277-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02277-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02277-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:35:16Z","timestamp":1787834116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02277-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":23,"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02277-y","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"29 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Nothing to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}